Choose Your Mounjaro Dose Strength Today
Complete Mounjaro Dose Range Available
EverydayMeds stocks every Mounjaro strength to support your complete treatment journey. Our GPhC-registered pharmacy maintains full inventory from 2.5mg starter doses through to 15mg maintenance therapy. Each prescription-only pen is clinically assessed to match your treatment stage and response.
Single Pen Pricing - All Strengths
Choose individual doses with first order savings. 2.5mg starter pens from £129.99 (first order) or £144.99 returning customers. Mid-range 7.5mg at £209.99 first order, £224.99 thereafter. Maximum strength 15mg available at £278.99 first order pricing. Every dose includes clinical assessment and MHRA-approved treatment.
Dose Progression Bundles
Our pharmacy bundles guide your treatment escalation. Intro Duo combines 2.5mg and 5mg pens for £299.99 first order - perfect for treatment initiation. Progress Trio includes 5mg, 7.5mg, and 10mg doses at £634.99 first order, supporting mid-treatment progression. Each bundle ensures smooth dose transitions.
Which Dose Strength Do You Need?
Treatment typically starts with 2.5mg weekly for four weeks, then increases to 5mg. Further escalation to 7.5mg, 10mg, 12.5mg, or 15mg depends on clinical response and tolerance. Our prescribers assess your progress and recommend appropriate dose progression during consultation.
Express Approval for All Doses
Standard clinical assessment completes within 3 working days for any dose strength. Upgrade to express service for 24-hour approval - ideal when continuing established treatment or switching doses. Both options include full prescriber review and dose appropriateness assessment.
Order Your Dose Today
Complete your online consultation to access prescription-only Mounjaro at the right dose strength. Our system guides you through medical history and current treatment status. Prescribers review your requirements and approve the appropriate dose for your weight management alongside diet and exercise. Start your clinical assessment now.
